Solitron Devices Q2 Sales Jump 42% to $5.66M, Backlog Hits Record $24.1M
SODI has more than doubled off its 52-week low of $16.
Summary
Solitron Devices reported fiscal Q2 2027 net sales of $5.66 million, up 42% year-over-year, with net income of $1.30 million ($0.60 per share) versus a net loss of $0.23 million a year ago. Backlog reached a record $24.11 million, up 29% from the prior year, and net bookings rose 48% to $6.42 million. The company also disclosed it retained an investment banker to explore strategic alternatives, incurring $200,000 in professional fees this quarter. Management expects sales to remain at or above current levels for the rest of fiscal 2027, with the next AMRAAM order anticipated in the fiscal fourth quarter. This follows a series of insider sales by Olesen Value Fund and a director's full stake sale in August, but the strong operational results and record backlog overshadow those concerns.
Updates
· SEC 10-Q — 10-Q filed: Q2 net sales $5.657M, net income $1.298M, backlog $24.1M; cash $7.357M, total assets $29.115M.
At the time of this announcement, SODI was trading at $33.97 on OTC in the Manufacturing sector, with a market capitalization of approximately $73.1M. The 52-week trading range was $16.00 to $35.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.